🇪🇺 Twinrix™ Adult in European Union

EMA authorised Twinrix™ Adult on 19 September 1996

Marketing authorisation

EMA — authorised 19 September 1996

  • Application: EMEA/H/C/000112
  • Marketing authorisation holder: GlaxoSmithKline Biologicals S.A.
  • Local brand name: Twinrix Adult
  • Indication: Twinrix Adult is indicated for use in non immune adults and adolescents 16 years of age and above who are at risk of both hepatitis A and hepatitis B infection.
  • Status: approved

Read official source →

Other Immunology / Infectious Disease approved in European Union

Frequently asked questions

Is Twinrix™ Adult approved in European Union?

Yes. EMA authorised it on 19 September 1996.

Who is the marketing authorisation holder for Twinrix™ Adult in European Union?

GlaxoSmithKline Biologicals S.A. holds the EU marketing authorisation.